Associated Papers
Overall cancer risk in people with deleterious germline DDX41 variants.
Korotev SC et al.
Haematologica, 2025
39945023 (PubMed )
Supplement: 2024_286887_KOROTEV_SUPPL.pdf
A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants.
Aboulkassim T et al.
Cell Reports, 2023
Proteogenomic Analysis of Protein Sequence Alterations in Breast Cancer Cells.
Lazar IM et al.
Scientific Reports, 2019
31316139 (PubMed )
Supplement: 41598_2019_46897_MOESM3_ESM.xlsx › Table_S1
Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.
Zhu Y et al.
Nature Communications, 2018
29500430 (PubMed )
Supplement: 41467_2018_3311_MOESM5_ESM.xlsx › SAAVs_and_orthogonal_evidence
Select a paper to view details